Association of plasma exosomes with severity of organ failure and mortality in patients with sepsis.
biomarker
exosomes
extracellular vesicles
organ failure
sepsis
Journal
Journal of cellular and molecular medicine
ISSN: 1582-4934
Titre abrégé: J Cell Mol Med
Pays: England
ID NLM: 101083777
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
27
03
2020
revised:
27
05
2020
accepted:
21
06
2020
pubmed:
9
7
2020
medline:
14
9
2021
entrez:
9
7
2020
Statut:
ppublish
Résumé
Current sepsis biomarkers may be helpful in determining organ failure and evaluating patient clinical course; however, direct molecular biomarkers to predict subsequent organ failure have not yet been discovered. Exosomes, a small population of extracellular vesicles, play an important role in the inflammatory response, coagulation process and cardiac dysfunction in sepsis. Nonetheless, the association of plasma exosome with severity and mortality of sepsis is not well known. Therefore, the overall levels of plasma exosome in sepsis patients were assessed and whether exosome levels were associated with organ failure and mortality was evaluated in the present study. Plasma level of exosomes was measured by ELISA. Among 220 patients with sepsis, 145 (66%) patients were diagnosed with septic shock. A trend of increased exosome levels in control, sepsis and septic shock groups was observed (204 µg/mL vs 525 µg/mL vs 802 µg/mL, P < 0.001). A positive linear relationship was observed between overall exosome levels and Sequential Organ Failure Assessment (SOFA) score in the study cohorts (r value = 0.47). When patients were divided into two groups according to best cut-off level, a statistical difference in 28- and 90-day mortality between patients with high and low plasma exosomes was observed. Elevated levels of plasma exosomes were associated with severity of organ failure and predictive of mortality in critically ill patients with sepsis.
Identifiants
pubmed: 32639098
doi: 10.1111/jcmm.15606
pmc: PMC7417686
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
9439-9445Informations de copyright
© 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.
Références
J Thromb Haemost. 2016 Jan;14(1):48-56
pubmed: 26564379
Crit Care. 2018 Mar 15;22(1):68
pubmed: 29540208
J Immunol. 2009 Nov 1;183(9):5983-90
pubmed: 19812188
Circ Res. 2011 May 13;108(10):1284-97
pubmed: 21566224
Crit Care. 2004 Dec;8(6):508-12
pubmed: 15566624
Clin Chim Acta. 2019 Jan;488:165-171
pubmed: 30419221
Theranostics. 2019 Jan 1;9(2):405-423
pubmed: 30809283
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
Int J Nanomedicine. 2012;7:1525-41
pubmed: 22619510
J Cell Mol Med. 2017 Oct;21(10):2403-2411
pubmed: 28382754
Biochem Biophys Res Commun. 2018 May 23;499(4):856-861
pubmed: 29625113
Physiol Rev. 2013 Jul;93(3):1247-88
pubmed: 23899564
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Mol Ther. 2018 May 2;26(5):1375-1384
pubmed: 29599080
Crit Care Med. 1985 Oct;13(10):818-29
pubmed: 3928249
Cancers (Basel). 2019 Apr 04;11(4):
pubmed: 30987321
Am J Respir Crit Care Med. 2013 Mar 1;187(5):509-17
pubmed: 23348975
Am J Respir Crit Care Med. 2014 Nov 15;190(10):1081-2
pubmed: 25398103
Semin Immunopathol. 2017 Jul;39(5):517-528
pubmed: 28555385
Front Immunol. 2014 Sep 16;5:442
pubmed: 25278937
J Clin Invest. 2016 Apr 1;126(4):1208-15
pubmed: 27035812
Intensive Care Med. 2005 Oct;31(10):1345-55
pubmed: 16132892
Crit Care. 2007;11(6):R120
pubmed: 17996049
Kidney Int. 2006 Nov;70(10):1847-57
pubmed: 17021608
Vascul Pharmacol. 2015 Aug;71:24-30
pubmed: 25869502
Sci Rep. 2015 Sep 08;5:13721
pubmed: 26348153
Nat Cell Biol. 2019 Jan;21(1):9-17
pubmed: 30602770
Crit Care. 2019 Feb 13;23(1):44
pubmed: 30760290
Am J Transl Res. 2018 Apr 15;10(4):1053-1070
pubmed: 29736200
In Vivo. 2013 Nov-Dec;27(6):669-84
pubmed: 24292568
Sci Rep. 2019 Dec 27;9(1):19887
pubmed: 31882721
JCI Insight. 2018 Jul 12;3(13):
pubmed: 29997296
Scand J Infect Dis. 2003;35(9):535-44
pubmed: 14620132
Front Immunol. 2019 Jul 12;10:1560
pubmed: 31354717
Am J Respir Crit Care Med. 2016 Aug 15;194(4):402-14
pubmed: 27337068
Am J Respir Crit Care Med. 2017 Aug 15;196(4):458-470
pubmed: 28107024
J Cell Mol Med. 2020 Aug;24(16):9439-9445
pubmed: 32639098
Circ Res. 2014 Jan 17;114(2):345-53
pubmed: 24436430